Blumenthal Cancer Center
New Inquiries: 201-634-5707
Our Current Patients: Click for directory

Brain Cancer

Font ++ Click to Print

The Valley Hospital Biorepository

For The Valley Hospital (TVH) patients undergoing surgical procedures, we offer the opportunity to participate in TVH Biorepository.  This protocol involves the freezing and storage of extra tissue not used for diagnosis, blood and other bodily fluids that may be used for future research designed to develop or contribute to generalized knowledge in cancer research. 



N0872 (Recurrent Glioblastoma)

“A Phase I/Randomized Phase II Double Blind Study of Either Dasatinib or Placebo Combined with Bevacizumab in Recurrent Glioblastoma”

Study objective: To estimate the efficacy of the bevacizumab combination with dasatinib in recurrent glioblastoma multiforme as measured by progression free survival at six months and compare it with the efficacy of bevacizumab alone.

Outcomes and
Innovations
Report






 
Find a Doctor
 
View all physicians
Contact the Blumenthal Cancer Center

Have a question? Call 201-634-5707 or complete the form below. If you are experiencing a medical emergency, please call your doctor or emergency services provider.

(-